Search for content and authors

New rosiglitazone salts

Anita Pietraszek ,  Michał Chodyński ,  Wioleta Maruszak ,  Andrzej Kutner 

Pharmaceutical Research Institute (IF), Rydygiera 8, Warszawa 01-793, Poland


The description of the new pharmaceutical salts of rosiglitazone was presented.

Rosiglitazone is an oral drug that reduces the glucose level in the blood. It is used for treating patients with type 2 diabetes and is in a class of anti-diabetic drugs called thiazolidinediones.

The possibilities to obtain of rosiglitazone salts with pharmaceutically acceptable organic acids were tested. The conditions of the synthesis for three possible new salts to obtain and also the technology for one of them were worked out.


Legal notice
  • Legal notice:

Related papers

Presentation: Poster at VI Multidyscyplinarna Konferencja Nauki o Leku, by Anita Pietraszek
See On-line Journal of VI Multidyscyplinarna Konferencja Nauki o Leku

Submitted: 2008-03-25 14:03
Revised:   2009-06-07 00:48